# Praxis Precision Medicines, Inc.: insider transactions

PRAX · Nasdaq · CIK 1689548 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/prax.md) · [Financials](/companies/prax/financials.md) · [Filings](/companies/prax/filings.md) · [Insiders](/companies/prax/insiders.md)

## All transactions: 17

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2021-10-06 | [BSOF Parallel Master Fund L.P.](/insiders/1736665.md) | 10% owner | Sale (S) | 400,000 | $17.50 | $7.0m | [Form 4](/filings/0000899243-21-039704.md) |
| 2021-10-05 | [BSOF Parallel Master Fund L.P.](/insiders/1736665.md) | 10% owner | Sale (S) | 23,946 | $19.15 | $458.6k | [Form 4](/filings/0000899243-21-039264.md) |
| 2021-10-01 | [BSOF Parallel Master Fund L.P.](/insiders/1736665.md) | 10% owner | Sale (S) | 22,600 | $19.13 | $432.3k | [Form 4](/filings/0000899243-21-039264.md) |
| 2021-08-23 | [BSOF Parallel Master Fund L.P.](/insiders/1736665.md) | 10% owner | Sale (S) | 771 | $20.04 | $15.5k | [Form 4](/filings/0000899243-21-034149.md) |
| 2021-08-23 | [BSOF Parallel Master Fund L.P.](/insiders/1736665.md) | 10% owner | Sale (S) | 351,625 | $19.00 | $6.7m | [Form 4](/filings/0000899243-21-034149.md) |
| 2021-08-18 | [BSOF Parallel Master Fund L.P.](/insiders/1736665.md) | 10% owner | Sale (S) | 3,000 | $15.88 | $47.6k | [Form 4](/filings/0000899243-21-033841.md) |
| 2021-08-12 | [BSOF Parallel Master Fund L.P.](/insiders/1736665.md) | 10% owner | Sale (S) | 10,060 | $13.92 | $140.0k | [Form 4](/filings/0000899243-21-032969.md) |
| 2021-08-11 | [BSOF Parallel Master Fund L.P.](/insiders/1736665.md) | 10% owner | Sale (S) | 17,222 | $15.03 | $258.8k | [Form 4](/filings/0000899243-21-032969.md) |
| 2021-08-03 | [BSOF Parallel Master Fund L.P.](/insiders/1736665.md) | 10% owner | Sale (S) | 22,300 | $14.99 | $334.3k | [Form 4](/filings/0000899243-21-031824.md) |
| 2021-08-02 | [BSOF Parallel Master Fund L.P.](/insiders/1736665.md) | 10% owner | Sale (S) | 40,000 | $15.78 | $631.2k | [Form 4](/filings/0000899243-21-031302.md) |
| 2021-07-30 | [BSOF Parallel Master Fund L.P.](/insiders/1736665.md) | 10% owner | Sale (S) | 15,854 | $15.68 | $248.6k | [Form 4](/filings/0000899243-21-031302.md) |
| 2020-10-20 | [Clarus Lifesciences III, L.P.](/insiders/1597143.md) | 10% owner | Conversion (C) | 164,832 | not reported | not reported | [Form 4](/filings/0000899243-20-029060.md) |
| 2020-10-20 | [Clarus Lifesciences III, L.P.](/insiders/1597143.md) | 10% owner | Conversion (C) | 907,378 | not reported | not reported | [Form 4](/filings/0000899243-20-029060.md) |
| 2020-10-20 | [Clarus Lifesciences III, L.P.](/insiders/1597143.md) | 10% owner | Conversion (C) | 261,318 | not reported | not reported | [Form 4](/filings/0000899243-20-029060.md) |
| 2020-10-20 | [Clarus Lifesciences III, L.P.](/insiders/1597143.md) | 10% owner | Conversion (C) | 659,116 | not reported | not reported | [Form 4](/filings/0000899243-20-029060.md) |
| 2020-10-20 | [Clarus Lifesciences III, L.P.](/insiders/1597143.md) | 10% owner | Conversion (C) | 2,361,198 | not reported | not reported | [Form 4](/filings/0000899243-20-029060.md) |
| 2020-10-20 | [Clarus Lifesciences III, L.P.](/insiders/1597143.md) | 10% owner | Conversion (C) | 3,446,711 | not reported | not reported | [Form 4](/filings/0000899243-20-029060.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.